PRGO
37
-3
FLR
43
10
NWS
75
4
IVZ
45
2
CHRW
64
2
PCAR
43
3
JNPR
54
2
PAYX
44
-6
LH
42
6
BDX
44
-2
MA
65
-2
R
70
7
PWR
41
-2
JBHT
50
5
INTC
47
4
CME
48
-4
DHI
31
3
BWA
34
5
KR
55
-2
OI
34
-3
PRGO
37
-3
FLR
43
10
NWS
75
4
IVZ
45
2
CHRW
64
2
PCAR
43
3
JNPR
54
2
PAYX
44
-6
LH
42
6
BDX
44
-2
MA
65
-2
R
70
7
PWR
41
-2
JBHT
50
5
INTC
47
4
CME
48
-4
DHI
31
3
BWA
34
5
KR
55
-2
OI
34
-3
Financhill
Back

Bioage Labs Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
40

BIOA
Bioage Labs

Last Price:
$4.78
Seasonality Move:
--
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
40
Bioage Labs (BIOA) is a Sell

Is Bioage Labs a Buy, Sell or Hold?

  • The current Bioage Labs [BIOA] share price is $4.79. The Score for BIOA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BIOA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIOA Stock Price Chart

What is Bioage Labs's stock price today?

  • The Bioage Labs share price today is $4.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIOA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BIOA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 41.13 Sell
Chaikin Money Flow: 104906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.5 - 5.16) Sell
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

BIOA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.51 Buy
20-day SMA: 4.83 Sell
50-day SMA: 6.07 Sell
200-day SMA: 0 Buy
8-day EMA: 4.58 Buy
20-day EMA: 4.88 Sell
50-day EMA: 6.9 Sell
200-day EMA: 6.98 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Bioage Labs Earnings Growth & BIOA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and a decrease next year of $0.50 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Bioage Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):